Coordinated phenotype switching with large-scale chromosome flip-flop inversion observed in bacteria

Genome inversions are ubiquitous in organisms ranging from prokaryotes to eukaryotes. Typical examples can be identified by comparing the genomes of two or more closely related organisms, where genome inversion footprints are clearly visible. Although the evolutionary implications of this phenomenon...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 109; no. 25; pp. E1647 - E1656
Main Authors Cui, Longzhu, Neoh, Hui-min, Iwamoto, Akira, Hiramatsu, Keiichi
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 19.06.2012
National Acad Sciences
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Genome inversions are ubiquitous in organisms ranging from prokaryotes to eukaryotes. Typical examples can be identified by comparing the genomes of two or more closely related organisms, where genome inversion footprints are clearly visible. Although the evolutionary implications of this phenomenon are huge, little is known about the function and biological meaning of this process. Here, we report our findings on a bacterium that generates a reversible, large-scale inversion of its chromosome (about half of its total genome) at high frequencies of up to once every four generations. This inversion switches on or off bacterial phenotypes, including colony morphology, antibiotic susceptibility, hemolytic activity, and expression of dozens of genes. Quantitative measurements and mathematical analyses indicate that this reversible switching is stochastic but self-organized so as to maintain two forms of stable cell populations (i.e., small colony variant, normal colony variant) as a bet-hedging strategy. Thus, this heritable and reversible genome fluctuation seems to govern the bacterial life cycle; it has a profound impact on the course and outcomes of bacterial infections.
Bibliography:http://dx.doi.org/10.1073/pnas.1204307109
Edited by Richard P. Novick, New York University School of Medicine, New York, NY, and approved December 1, 2011 (received for review March 16, 2012)
Author contributions: L.C. and K.H. designed research; L.C. and H.-m.N. performed research; L.C. and A.I. analyzed data; and L.C., H.-m.N., A.I., and K.H. wrote the paper.
2Present address: Research Center for Antiinfectious Drugs, Kitasato Institute for Life Science, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
3Present address: UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1204307109